Quantinno Capital Management’s Praxis Precision Medicines PRAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.28M Buy
4,411
+703
+19% +$233K ﹤0.01% 2577
2026
Q2
$1.24M Buy
3,708
+388
+12% +$123K ﹤0.01% 2401
2026
Q1
$1.07M Buy
3,320
+597
+22% +$185K ﹤0.01% 2098
2025
Q4
$803K Buy
+2,723
New +$507K ﹤0.01% 1975

Other funds holding PRAX

Quantinno Capital Management's PRAX Position: Q3 2026 in Review

Quantinno Capital Management increased its Praxis Precision Medicines (PRAX) stake by 19% in Q3 2026, buying an estimated $233K and bringing the position to 4,411 shares worth $1.28M. The position accounts for ﹤0.01% of the portfolio, ranked #2577.

Quantinno Capital Management first reported a position in PRAX in Q4 2025 and has held it in 4 quarters since. 336 funds tracked by Wall St. Rank hold PRAX as of Q3 2026.

  • Quantinno Capital Management held 4,411 shares of Praxis Precision Medicines worth $1.28M as of Q3 2026.
  • Quantinno Capital Management bought 703 Praxis Precision Medicines shares in Q3 2026, an estimated $233K.
  • Praxis Precision Medicines made up ﹤0.01% of Quantinno Capital Management's portfolio in Q3 2026, its #2577 holding.
  • Quantinno Capital Management first reported a position in Praxis Precision Medicines in Q4 2025 and has held it in 4 quarters since.
  • 336 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2026.

Based on Quantinno Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.